It’s Remestemcel-L for pediatric GVHD.
This is closest to commercialization and majority of holders here believe it will be FDA approved within 12 months.
It’s Remestemcel-L for pediatric GVHD.This is closest to...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.078(7.14%) |
Mkt cap ! $1.358B | |||
| Open | High | Low | Value | Volume |
| $1.12 | $1.20 | $1.11 | $8.872M | 7.599M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 12763 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 40916 | 4 |
View Market Depth
| Last trade - 11.20am 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.18 |
Change
0.078 ( 8.39 %) |
||||
| Open | High | Low | Volume | ||
| $1.12 | $1.20 | $1.12 | 1918674 | ||
| Last updated 11.40am 06/05/2024 ? | |||||
| MSB (ASX) Chart |